Bases Neurobiológicas y Psicológicas de los Trastornos Mentales. Trastornos del Neurodesarrollo

Arango, C; Garibaldi, G; Marder, SR.

Pharmacological approaches to treating negative symptoms: A review of clinical trials

Schizophrenia Research. 2013; 150(2-3): 346-352 Nº de citas: 77 [doi:10.1016/j.schres.2013.07.026]

Garcia-Portilla, MP; Gomar, JJ; Bobes-Bascaran, MT; Menendez-Miranda, I; Saiz, PA; Muniz, J; Arango, C; Patterson, TL; Harvey, PD; Bobes, J; Goldberg, TE.

Validation of a European Spanish-version of the University of California performance Skills Assessment (Sp-UPSA) in patients with schizophrenia and bipolar disorder

Schizophrenia Research. 2013; 150(2-3): 421-426 Nº de citas: 25 [doi:10.1016/j.schres.2013.07.049]

Caamano, M; Boada, L; Merchan-Naranjo, J; Moreno, C; Llorente, C; Moreno, D; Arango, C; Parellada, M.

Psychopathology in Children and Adolescents with ASD Without Mental Retardation

JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS. 2013; 43(10): 2442-2449 Nº de citas: 44 [doi:10.1007/s10803-013-1792-0]

Moreno, C; Nuevo, R; Chatterji, S; Verdes, E; Arango, C; Ayuso-Mateos, JL.

Psychotic symptoms are associated with physical health problems independently of a mental disorder diagnosis: results from the WHO World Health Survey

World Psychiatry. 2013; 12(3): 251-257 Nº de citas: 95 [doi:10.1002/wps.20070]

Aleman-Gomez, Y; Janssen, J; Schnack, H; Balaban, E; Pina-Camacho, L; Alfaro-Almagro, F; Castro-Fornieles, J; Otero, S; Baeza, I; Moreno, D; Bargallo, N; Parellada, M; Arango, C; Desco, M.

The Human Cerebral Cortex Flattens during Adolescence

JOURNAL OF NEUROSCIENCE. 2013; 33(38): 15004-15010 Nº de citas: 101 [doi:10.1523/JNEUROSCI.1459-13.2013]

Torrent, C; Bonnin, CDM; Martinez-Aran, A; Valle, J; Amann, BL; Gonzalez-Pinto, A; Crespo, JM; Ibanez, A; Garda-Portilla, MP; Tabares-Seisdedos, R; Arango, C; Colom, F; Sole, B; Pacchiarotti, I; Rosa, AR; Ayuso-Mateos, JL; Anaya, C; Fernandez, P; Landin-Romero, R; Alonso-Lana, S; Ortiz-Gil, J; Segura, B; Barbeito, S; Vega, P; Fernandez, M; Ugarte, A; Subira, M; Cerrillo, E; Custal, N; Menchon, JM; Saiz-Ruiz, J; Rodao, JM; Isella, S; Alegria, A; Al-Lialabi, S; Bobes, J; Galvan, G; Saiz, LA; Balanza-Martinez, V; Selva, G; Fuentes-Dura, I; Correa, P; Mayoral, M; Chiclana, G; Merchan-Naranjo, J; Rapado-Castro, M; Salamero, M; Vieta, E.

Efficacy of Functional Remediation in Bipolar Disorder: A Multicenter Randomized Controlled Study

AMERICAN JOURNAL OF PSYCHIATRY. 2013; 170(8): 852-859 Nº de citas: 247 [doi:10.1176/appi.ajp.2012.12070971]

Noguera, A; Ballesta, P; Baeza, I; Arango, C; de la Serna, E; Gonzalez-Pinto, A; Parellada, M; Graell, M; Moreno, C; Otero, S; Castro-Fornieles, J.

Twenty-Four Months of Antipsychotic Treatment in Children and Adolescents With First Psychotic Episode Discontinuation and Tolerability

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY. 2013; 33(4): 463-471 Nº de citas: 23 [doi:10.1097/JCP.0b013e3182962480]

Ibanez-Casas, I; De Portugal, E; Gonzalez, N; McKenney, KA; Haro, JM; Usall, J; Perez-Garcia, M; Cervilla, JA.

Deficits in Executive and Memory Processes in Delusional Disorder: A Case-Control Study

PLoS One. 2013; 8(7): Nº de citas: 27 [doi:10.1371/journal.pone.0067341]

Salvador-Carulla, L; Garcia-Gutierrez, JC; Gutierrez-Colosia, MR; Artigas-Pallares, J; Ibanez, JG; Perez, JG; Pla, MN; Ines, FA; Isus, S; Cereza, JM; Poole, M; Lazcano, GP; Monzon, P; Leiva, M; Parellada, M; Nonell, KG; Hernandez, AMI; Rigau, E; Martinez-Leal, R.

Borderline Intellectual Functioning: Consensus and good practice guidelines

Spanish Journal of Psychiatry and Mental Health. 2013; 6(3): 109-120 Nº de citas: 65 [doi:10.1016/j.rpsm.2012.12.001]

Nuevo, R; Van Os, J; Arango, C; Chatterji, S; Ayuso-Mateos, JL.

Evidence for the early clinical relevance of hallucinatory-delusional states in the general population

ACTA PSYCHIATRICA SCANDINAVICA. 2013; 127(6): 482-493 Nº de citas: 44 [doi:10.1111/acps.12010]

Garcia-Amador, M; de la Serna, E; Vila, M; Romero, S; Valenti, M; Sanchez-Gistau, V; Benabarre, A; Vieta, E; Castro-Fornieles, J.

Parents with bipolar disorder: Are disease characteristics good predictors of psychopathology in offspring?

EUROPEAN PSYCHIATRY. 2013; 28(4): 240-246 Nº de citas: 17 [doi:10.1016/j.eurpsy.2012.03.006]

Paya, B; Rodriguez-Sanchez, JM; Otero, S; Munoz, P; Castro-Fornieles, J; Parellada, M; Gonzalez-Pinto, A; Soutullo, C; Baeza, I; Rapado-Castro, M; Saenz-Herrero, M; Moreno, D; Arango, C.

Premorbid impairments in early-onset psychosis: Differences between patients with schizophrenia and bipolar disorder

Schizophrenia Research. 2013; 146(1-3): 103-110 Nº de citas: 29 [doi:10.1016/j.schres.2013.01.029]

de Portugal, E; Gonzalez, N; del Amo, V; Haro, JM; Diaz-Caneja, CM; del Castillo, JDL; Cervilla, JA.

Empirical redefinition of delusional disorder and its phenomenology: the DELIREMP study

COMPREHENSIVE PSYCHIATRY. 2013; 54(3): 243-255 Nº de citas: 31 [doi:10.1016/j.comppsych.2012.08.002]

Bombin, I; Mayoral, M; Castro-Fornieles, J; Gonzalez-Pinto, A; de la Serna, E; Rapado-Castro, M; Barbeito, S; Parellada, M; Baeza, I; Graell, M; Paya, B; Arango, C.

Neuropsychological evidence for abnormal neurodevelopment associated with early-onset psychoses

PSYCHOLOGICAL MEDICINE. 2013; 43(4): 757-768 Nº de citas: 59 [doi:10.1017/S0033291712001535]

Pina-Camacho, L; Villero, S; Boada, L; Fraguas, D; Janssen, J; Mayoral, M; Llorente, C; Arango, C; Parellada, M.

Structural magnetic resonance imaging data do not help support DSM-5 autism spectrum disorder category

Research in Autism Spectrum Disorders. 2013; 7(2): 333-343 Nº de citas: 5 [doi:10.1016/j.rasd.2012.08.013]

Parellada, M; Boada, L; Moreno, C; Llorente, C; Romo, J; Muela, C; Arango, C.

Specialty Care Programme for autism spectrum disorders in an urban population: A case-management model for health care delivery in an ASD population

EUROPEAN PSYCHIATRY. 2013; 28(2): 102-109 Nº de citas: 25 [doi:10.1016/j.eurpsy.2011.06.004]

Darba, J; Kaskens, L; Aranda, P; Arango, C; Bobes, J; Carmena, R; Rejas, J.

A simulation model to estimate 10-year risk of coronary heart disease events in patients with schizophrenia spectrum disorders treated with second-generation antipsychotic drugs

Annals of Clinical Psychiatry. 2013; 25(1): 17-26 Nº de citas: 6

MacDowell, KS; Garcia-Bueno, B; Madrigal, JLM; Parellada, M; Arango, C; Mico, JA; Leza, JC.

Risperidone normalizes increased inflammatory parameters and restores anti-inflammatory pathways in a model of neuroinflammation

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2013; 16(1): 121-135 Nº de citas: 97 [doi:10.1017/S1461145711001775]